Mono-USO SA
2.8 FTEMono-USO reported total assets of €10.1m at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jun 2026), with 2.8 full-time equivalents.
The score of Mono-USO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets +3 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mono-USO's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 03 Jun 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Mono-USO's financial analysis
- Solvency96.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mono-USO
Mono-USO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0867.442.789
- VAT number
- BE0867442789
- Peppol
- Registered · 0208:0867442789 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Sep 2004
- Registered office
- 8790 Waregem
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 01 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Mono-USO (SA) has been based in Waregem since 2004, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 15,947 € and equity of €9.74m; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 96.6%, above the median of its sector (46.0%).
Companies similar to Mono-USO
Companies in the same business, of comparable size and area, outside its group.
- Laboratoires Lohmann & Rauscher Manufacture of pharmaceutical preparations Liège · balance sheet €4.03m
- Departement Central DE Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Sarco Manufacture of outerwear Temse · balance sheet €9.55m
- Omega Pharma International Wholesale of pharmaceutical and medical goods Ghent · balance sheet €100.5m
- Ansell Healthcare Europe Manufacture of other wearing apparel and accessories n.e.c. Anderlecht · balance sheet €400.0m
- M.Ex.T. BELGIUM Wholesale of pharmaceutical and medical goods Roeselare · balance sheet €13.6m
- Lagae Jozef EN Zonen - Vlashandel EN - Nijverheid - Lagae Joseph ET Fils - Commerce ET Industrie DU LIN Wholesale of pharmaceutical and medical goods Kuurne · balance sheet €8.77m
- Zambon Wholesale of pharmaceutical and medical goods Jette · balance sheet €7.67m
Frequently asked questions about Mono-USO
What is the revenue of Mono-USO?
Mono-USO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mono-USO?
In Belgium, the VAT number is the company number prefixed with BE: BE0867442789 for Mono-USO, if the company is VAT-registered. Its company number (CBE) is 0867.442.789.
Where is the registered office of Mono-USO?
According to the CBE register, the registered office of Mono-USO is in 8790 Waregem.
What is the equity of Mono-USO?
At the close of the 2025 financial year, the equity of Mono-USO amounts to 9,743,526 €, a solvency of 96.6% of total assets.
How many people work at Mono-USO?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Mono-USO?
The register lists 4 active mandates at Mono-USO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mono-USO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →